Stay updated on Flotetuzumab in PIF/ER AML Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab in PIF/ER AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    No significant changes were detected on the Study Details page for NCT02152956; the title, URL, and primary content appear unchanged.
    Difference
    0.2%
    Check dated 2025-11-03T20:56:50.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.
    Difference
    2%
    Check dated 2025-10-06T05:19:11.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T03:02:12.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2 and the Back to Top element was removed. This is a minor metadata/UI change with no impact on core content, pricing, stock, or time slots.
    Difference
    0.1%
    Check dated 2025-09-14T18:58:45.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T14:18:25.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information for Ruxolitinib and relevant medical topics related to leukemia, while also changing the facility name and location details. Previous location details and certain genetic disease resources have been removed.
    Difference
    2%
    Check dated 2025-08-31T11:44:33.000Z thumbnail image

Stay in the know with updates to Flotetuzumab in PIF/ER AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.